CRINTUM CV DRY SYRUP
This combination contains Cefuroxime Axetil 125 mg, a second-generation cephalosporin antibiotic, and Potassium Clavulanate 31.25 mg, a beta-lactamase inhibitor.
Cefuroxime Axetil: Works by inhibiting bacterial cell wall synthesis, killing the infection-causing bacteria.
Potassium Clavulanate: Prevents resistant bacteria from inactivating Cefuroxime, thereby enhancing its antibacterial activity.
Available in Dry syrup form for paediatric use.
It is commonly prescribed for treating bacterial infections such as:
Respiratory tract infections – pneumonia, sinusitis, bronchitis, tonsillitis, pharyngitis
Ear infections (otitis media)
Urinary tract infections (UTIs)
Skin and soft tissue infections
Bone and joint infections
Infections caused by beta-lactamase–producing resistant bacteria